A detailed history of Quantamental Technologies LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 10,329 shares of CHRS stock, worth $14,770. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,329
Holding current value
$14,770
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$3.74 - $5.45 $38,630 - $56,293
10,329 New
10,329 $38,000
Q1 2023

May 15, 2023

BUY
$5.89 - $10.52 $97,991 - $175,021
16,637 New
16,637 $113,000
Q4 2019

Feb 14, 2020

SELL
$16.33 - $21.37 $201,267 - $263,385
-12,325 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$16.3 - $23.37 $200,897 - $288,035
12,325 New
12,325 $250,000
Q1 2019

Apr 29, 2019

SELL
$8.38 - $15.5 $10,776 - $19,933
-1,286 Closed
0 $0
Q4 2018

Jan 28, 2019

BUY
$8.65 - $16.28 $11,123 - $20,936
1,286 New
1,286 $12,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $111M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.